The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.
Source: https://www.cnbc.com/2024/04/16/johnson ... -2024.html
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
